In the event of a pandemic, our policy is to provide treatment to all who need it, irrespective of the profession to which they belong. We are currently increasing our antiviral stockpile to ensure that there will be enough to treat up to 50 per cent. of the population in a pandemic, the reasonable worst case scenario of the number of people likely to exhibit symptoms of pandemic influenza. This stockpile is due to be in place by April 2009.